Top

Published in:

Open Access 18-12-2023 | Cephalexin | Original Research Article

Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in India

Authors: Kalyan Banerjee, Ajay Kakkar, Kashif Ahmed Shamsi, Deepak Bansal, Priyesh Mathur, Nitin Madan Potode, Pankaj Pagariya, Sha Perveez Azher, Apurva Chaudhari, Ritu Mandal, Archana S. Karadkhele, Neeraj Markandeywar, Shruti Dharmadhikari, Chintan Khandhedia, Amey Mane, Suyog Mehta, Sadhna Joglekar

Published in: Drugs - Real World Outcomes | Issue 1/2024

Abstract

Background

Despite multiple antibiotics being available to manage dental infections (DI), there is lack of data comparing commonly prescribed antibiotics in India.

Objectives

The aim of this study was to evaluate the real-world effectiveness and tolerability of cephalexin-clavulanic acid fixed-dose combination (cephalexin CV FDC) in contrast with amoxicillin-clavulanic acid (co-amoxiclav FDC) and cefuroxime among patients with dental infections (odontogenic) in India.

Methods

This retrospective, multi-centric, observational, real-world electronic medical record (EMR)-based study was conducted between January 2022 and December 2022. The EMRs of 355 adults with DI receiving oral cephalexin CV, co-amoxiclav, or cefuroxime were categorized into two distinct groups: Group I (Test Group) with patients prescribed cephalexin extended release 375/750 mg along with clavulanic acid 125 mg; and Group II (Comparator Group) with patients prescribed co-amoxiclav 625 mg (500 mg amoxicillin + 125 mg clavulanic acid) or cefuroxime (250 mg/500 mg).

Results

Toothache was the most common complaint, reported by 95.5% of patients, followed by swelling (46.8%), tooth sensitivity (35.5%), pus discharge (33.0%), redness and halitosis (30.4% each). Dental caries was observed in 81.1% of patients. Clinical improvement, defined as improvement/partial resolution of infection-related clinical signs and symptoms (composite measure of pain, swelling, fever, requirement of additional antimicrobial therapy) as per dentists’ judgment, was recorded in 98.3% of patients with cephalexin CV, 96.8% of patients with co-amoxiclav, and 98.9% of patients treated with cefuroxime within 10 days. Time (days) to clinical improvement was numerically lesser among patients receiving cephalexin CV (4.6 ± 2.0) compared with cefuroxime (4.9 ± 2.1) and co-amoxiclav (5.0 ± 2.6). All treatments were well tolerated.

Conclusion

Cephalexin CV was as effective as co-amoxiclav and cefuroxime, with faster clinical improvement and better resolution of certain symptoms.

Ortiz R, Espinoza V. Odontogenic infection. Review of the pathogenesis, diagnosis, complications and treatment. Res Rep Oral Maxillofac Surg. 2021;5:055.

Neal TW, Schlieve T. Complications of severe odontogenic infections: a review. Biology (Basel). 2022. https://doi.org/10.3390/biology11121784.CrossRefPubMed

Ogle OE. Odontogenic infections. Dent Clin North Am. 2017;61:235–52. https://doi.org/10.1016/j.cden.2016.11.004.CrossRefPubMed

Bernabe E, Marcenes W, Hernandez CR, Bailey J, Abreu LG, Alipour V, Amini S, Arabloo J, Arefi Z, Arora A, et al. Global, regional, and national levels and trends in burden of oral conditions from 1990 to 2017: a systematic analysis for the global burden of disease 2017 study. J Dent Res. 2020;99:362–73. https://doi.org/10.1177/0022034520908533.CrossRefPubMed

Erazo D, Whetstone DR. Dental infections. StatPearls Publishing; 2023.

Gonçalves L, Lauriti L, Yamamoto MK, Luz JG. Characteristics and management of patients requiring hospitalization for treatment of odontogenic infections. J Craniofac Surg. 2013;24:e458-462. https://doi.org/10.1097/SCS.0b013e3182902e95.CrossRefPubMed

Patil R, Gondivkar SM, Gadbail AR, Yuwanati M, Mankar M, Likhitkar M, Sarode S, Sarode G, Patil S. Role of oral foci in systemic diseases: an update. Int J Contemp Dent Med Rev. 2017. https://doi.org/10.15713/ins.ijcdmr.115.CrossRef

Seymour RA. Is gum disease killing your patient? Br Dent J. 2009;206:551–2. https://doi.org/10.1038/sj.bdj.2009.472.CrossRefPubMed

Donkor ES, Kotey FC. Methicillin-resistant Staphylococcus aureus in the oral cavity: implications for antibiotic prophylaxis and surveillance. Infect Dis. 2020;13:1178633720976581. https://doi.org/10.1177/1178633720976581.CrossRef

10.

Meinen A, Reuss A, Willrich N, Feig M, Noll I, Eckmanns T, Al-Nawas B, Markwart R. Antimicrobial resistance and the spectrum of pathogens in dental and oral-maxillofacial infections in hospitals and dental practices in Germany. Front Microbiol. 2021;12: 676108. https://doi.org/10.3389/fmicb.2021.676108.CrossRefPubMedPubMedCentral

11.

Garbacz K, Jarzembowski T, Kwapisz E, Daca A, Witkowski J. Do the oral Staphylococcus aureus strains from denture wearers have a greater pathogenicity potential? J Oral Microbiol. 2018;11:1536193. https://doi.org/10.1080/20002297.2018.1536193.CrossRefPubMedPubMedCentral

12.

Kumar N, Khare VV, Jamdade A, Aggarwal A, Rathore NS, Yadav S. Antibiotic susceptibility of the bacteria causing odontogenic infections: an observational study. J Indian Acad Oral Med Radiol. 2022;34:442–6. https://doi.org/10.4103/jiaomr.jiaomr_194_22.CrossRef

13.

Ahmadi H, Ebrahimi A, Ahmadi F. Antibiotic therapy in dentistry. Int J Dent. 2021;2021:6667624. https://doi.org/10.1155/2021/6667624.CrossRefPubMedPubMedCentral

14.

MoHFW. Standard Treatment guidelines for Oral Health. 2010. Available from: https://main.mohfw.gov.in/sites/default/files/N_56820_1613385504626.pdf. Accessed 12 June 2023.

15.

Ramu C, Padmanabhan TV. Indications of antibiotic prophylaxis in dental practice—review. Asian Pac J Trop Biomed. 2012;2:749–54. https://doi.org/10.1016/s2221-1691(12)60222-6.CrossRefPubMedPubMedCentral

16.

Bui T, Preuss CV. Cephalosporins. StatPearls Publishing; 2022.

17.

Tartaglione TA, Polk RE. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Drug Intell Clin Pharm. 1985;19:188–98. https://doi.org/10.1177/106002808501900304.CrossRefPubMed

18.

Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23:160–201. https://doi.org/10.1128/cmr.00037-09.CrossRefPubMedPubMedCentral

19.

Sobottka I, Cachovan G, Stürenburg E, Ahlers MO, Laufs R, Platzer U, Mack D. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother. 2002;46:4019–21. https://doi.org/10.1128/aac.46.12.4019-4021.2002.CrossRefPubMedPubMedCentral

20.

Kumar KP, Kaushik M, Kumar PU, Reddy MS, Prashar N. Antibiotic prescribing habits of dental surgeons in hyderabad city, India, for pulpal and periapical pathologies: a survey. Adv Pharmacol Sci. 2013;2013: 537385. https://doi.org/10.1155/2013/537385.CrossRefPubMedPubMedCentral

21.

WHO global oral health report. 2022. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/odi.14516. Accessed 22 June 2023.

22.

Haque M, Sartelli M, Haque SZ. Dental infection and resistance-global health consequences. Dent J (Basel). 2019. https://doi.org/10.3390/dj7010022.CrossRefPubMed

23.

Monasteri R, Henriquez SG. Prevalence and characterization of Odontogenic Infections in the Public Assistance Emergency Hospital between the Months of July to September of the Year 2015: Prospective Study. EC Dental Science. 2018;17:880–91.

24.

Topazian RG, Goldberg MH, Hupp JR. Oral and maxillofacial infections. Saunders; 2002.

25.

Seppänen L, Rautemaa R, Lindqvist C, Lauhio A. Changing clinical features of odontogenic maxillofacial infections. Clin Oral Investig. 2010;14:459–65. https://doi.org/10.1007/s00784-009-0281-5.CrossRefPubMed

26.

Mahmoodi B, Weusmann J, Azaripour A, Braun B, Walter C, Willershausen B. Odontogenic infections: a 1-year retrospective study. J Contemp Dent Pract. 2015;16:253–8. https://doi.org/10.5005/jp-journals-10024-1671.CrossRefPubMed

27.

Tadjoedin FM, Fitri AH, Kuswandani SO, Sulijaya B, Soeroso Y. The correlation between age and periodontal diseases. J Int Dental Med Res. 2017;10:327.

28.

Hunt DE, King TJ, Fuller GE. Antibiotic suseptibility of bacteria isolated from oral infections. J Oral Surg. 1978;36:527–9.PubMed

29.

Pandey P, Nandkeoliar T, Tikku AP, Singh D, Singh MK. Prevalence of dental caries in the Indian population: a systematic review and meta-analysis. J Int Soc Prev Community Dent. 2021;11:256–65. https://doi.org/10.4103/jispcd.JISPCD_42_21.CrossRefPubMedPubMedCentral

30.

Shakya N, Sharma D, Newaskar V, Agrawal D, Shrivastava S, Yadav R. Epidemiology, microbiology and antibiotic sensitivity of odontogenic space infections in Central India. J Maxillofac Oral Surg. 2018;17:324–31. https://doi.org/10.1007/s12663-017-1014-y.CrossRefPubMed

31.

WHO. Oral health. 2023. Available from: https://cdn.who.int/media/docs/default-source/ncds/mnd/oral-health/eb152-draft-global-oral-health-action-plan-2023-2030-en.pdf. Accessed 22 June 2023.

32.

Maheswaran T, Ramesh V, Krishnan A, Joseph J. Common chief complaints of patients seeking treatment in the government dental institution of Puducherry, India. J Indian Acad Dent Spec Res. 2015;2:55–8.CrossRef

33.

Abdullah BA, Al-Tuhafi AA. Chief complaints of patients attending college of Dentistry at Mosul University. Al-Rafidain Dental J. 2007;7:201–5.CrossRef

34.

Masiga M. Presenting chief complaints and clinical characteristics among patients attending the Department of Paediatric Dentistry Clinic at the University of Nairobi Dental Hospital. East Afr Med J. 2005;82:652–5.PubMed

35.

Labh AK, Ramani P. Prevalence of periodontal abscess among patients visiting a private dental college and hospital in Chennai, India. Indian J Forensic Med Toxicol. 2020;14:5081–92.

36.

Sanders JL, Houck RC. Dental abscess. Treasure Island: StatPearls Publishing LLC; 2023.

37.

Henry M, Reader A, Beck M. Effect of penicillin on postoperative endodontic pain and swelling in symptomatic necrotic teeth. Journal of endodontics. 2001;27:117–23.CrossRefPubMed

38.

Tancawan AL, Pato MN, Abidin KZ, Asari AS, Thong TX, Kochhar P, Muganurmath C, Twynholm M, Barker K. Amoxicillin/clavulanic acid for the treatment of odontogenic infections: a randomised study comparing efficacy and tolerability versus clindamycin. Int J Dent. 2015;2015: 472470. https://doi.org/10.1155/2015/472470.CrossRefPubMedPubMedCentral

39.

Kumari S, Mohanty S, Sharma P, Dabas J, Kohli S, Diana C. Is the routine practice of antibiotic prescription and microbial culture and antibiotic sensitivity testing justified in primary maxillofacial space infection patients? A prospective, randomized clinical study. J Craniomaxillofac Surg. 2018;46:446–52. https://doi.org/10.1016/j.jcms.2017.11.026.CrossRefPubMed

40.

Lockhart PB, Tampi MP, Abt E, Aminoshariae A, Durkin MJ, Fouad AF, Gopal P, Hatten BW, Kennedy E, Lang MS, et al. Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling: a report from the American Dental Association. J Am Dent Assoc. 2019;150:906-921.e912. https://doi.org/10.1016/j.adaj.2019.08.020.CrossRefPubMedPubMedCentral

41.

Horii M, Morinaga T, Shimada S, Takeuchi T, Yamanaka H, Nishimura T, Noshi Y, Okada T, Sasaki T, Ikeda S, et al. Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author’s transl). Jpn J Antibiot. 1980;33:1194–214.PubMed

42.

Matijević S, Lazić Z, Kuljić-Kapulica N, Nonković Z. Empirical antimicrobial therapy of acute dentoalveolar abscess. Vojnosanit Pregl. 2009;66:544–50. https://doi.org/10.2298/vsp0907544m.CrossRefPubMed

43.

Buttar R, Aleksejūnienė J, Coil J. Antibiotic and opioid analgesic prescribing patterns of dentists in Vancouver and endodontic specialists in British Columbia. J Can Dent Assoc. 2017;83: h8.PubMed

44.

Maslamani M, Sedeqi F. Antibiotic and analgesic prescription patterns among dentists or management of dental pain and infection during endodontic treatment. Med Princ Pract. 2018;27:66–72. https://doi.org/10.1159/000486416.CrossRefPubMed

45.

Dana R, Azarpazhooh A, Laghapour N, Suda KJ, Okunseri C. Role of dentists in prescribing opioid analgesics and antibiotics: an overview. Dent Clin North Am. 2018;62:279–94. https://doi.org/10.1016/j.cden.2017.11.007.CrossRefPubMed

46.

Sasaki I, Morihana T, Kaneko A, Michi K, Takahashi K, Fukuoka F, Satoh T, Yoshinari N, Ohne M, Hara H, et al. Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor. Jpn J Antibiot. 1990;43:2035–68.PubMed

47.

Kuriyama T, Karasawa T, Nakagawa K, Nakamura S, Yamamoto E. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics. Oral Microbiol Immunol. 2002;17:285–9. https://doi.org/10.1034/j.1399-302x.2002.170504.x.CrossRefPubMed

48.

Al-Qamachi LH, Aga H, McMahon J, Leanord A, Hammersley N. Microbiology of odontogenic infections in deep neck spaces: a retrospective study. Br J Oral Maxillofac Surg. 2010;48:37–9. https://doi.org/10.1016/j.bjoms.2008.12.007.CrossRefPubMed

Title: Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in India
Authors: Kalyan Banerjee
Ajay Kakkar
Kashif Ahmed Shamsi
Deepak Bansal
Priyesh Mathur
Nitin Madan Potode
Pankaj Pagariya
Sha Perveez Azher
Apurva Chaudhari
Ritu Mandal
Archana S. Karadkhele
Neeraj Markandeywar
Shruti Dharmadhikari
Chintan Khandhedia
Amey Mane
Suyog Mehta
Sadhna Joglekar
Publication date: 18-12-2023
Publisher: Springer International Publishing
Keywords: Cephalexin
Cefuroxime
Amoxicillin
Antibiotic
Caries
Halitosis
Halitosis
Published in: Drugs - Real World Outcomes / Issue 1/2024
Print ISSN: 2199-1154
Electronic ISSN: 2198-9788
DOI: https://doi.org/10.1007/s40801-023-00406-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in India

Abstract

Background

Objectives

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study

Evaluation of Triple Whammy Prescriptions After the Implementation of a Drug Safety Algorithm

The Association between Deductibles and Cardiovascular Medication Adherence: A Retrospective Inception Cohort Study

Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study

Outcomes of a Medication Optimization Virtual Interdisciplinary Geriatric Specialist (MOVING) Program: A Feasibility Study

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database